United States Prophylactic Pediatric Vaccines Market Research Report Forecast 2017-2021

April 2017 | 124 pages | ID: U0C982E9E5BEN
S&P Consulting

Abstracts

The United States Prophylactic Pediatric Vaccines Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Prophylactic Pediatric Vaccines industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Prophylactic Pediatric Vaccines market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
ALK - Abello A/S (Denmark)
Altimmune, Inc. (US)
Bavarian Nordic A/S (Denmark)
BiondVax Pharmaceuticals Ltd. (Israel)
Bharat Biotech International Limited (India)
GlaxoSmithKline Plc. (UK)
Hualan Biological Engineering Inc. (China)
Janssen Pharmaceuticals, Inc. (US)
MedImmune (US)

United States Prophylactic Pediatric Vaccines Market: Product Segment Analysis
Type 1
Type 2
Type 3

United States Prophylactic Pediatric Vaccines Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 PROPHYLACTIC PEDIATRIC VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Prophylactic Pediatric Vaccines
1.2 Prophylactic Pediatric Vaccines Market Segmentation by Type
  1.2.1 United States Production Market Share of Prophylactic Pediatric Vaccines by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Prophylactic Pediatric Vaccines Market Segmentation by Application
  1.3.1 Prophylactic Pediatric Vaccines Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Prophylactic Pediatric Vaccines (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON PROPHYLACTIC PEDIATRIC VACCINES INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES PROPHYLACTIC PEDIATRIC VACCINES MARKET COMPETITION BY MANUFACTURERS

3.1 United States Prophylactic Pediatric Vaccines Production and Share by Manufacturers (2015 and 2016)
3.2 United States Prophylactic Pediatric Vaccines Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Prophylactic Pediatric Vaccines Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Prophylactic Pediatric Vaccines Manufacturing Base Distribution, Production Area and Product Type
3.5 Prophylactic Pediatric Vaccines Market Competitive Situation and Trends
  3.5.1 Prophylactic Pediatric Vaccines Market Concentration Rate
  3.5.2 Prophylactic Pediatric Vaccines Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES PROPHYLACTIC PEDIATRIC VACCINES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Prophylactic Pediatric Vaccines Production and Market Share by Type (2012-2017)
4.2 United States Prophylactic Pediatric Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Prophylactic Pediatric Vaccines Price by Type (2012-2017)
4.4 United States Prophylactic Pediatric Vaccines Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES PROPHYLACTIC PEDIATRIC VACCINES MARKET ANALYSIS BY APPLICATION

5.1 United States Prophylactic Pediatric Vaccines Consumption and Market Share by Application (2012-2017)
5.2 United States Prophylactic Pediatric Vaccines Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES PROPHYLACTIC PEDIATRIC VACCINES MANUFACTURERS ANALYSIS

6.1 ALK - Abello A/S (Denmark)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Altimmune, Inc. (US)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Bavarian Nordic A/S (Denmark)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 BiondVax Pharmaceuticals Ltd. (Israel)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Bharat Biotech International Limited (India)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 GlaxoSmithKline Plc. (UK)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Hualan Biological Engineering Inc. (China)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Janssen Pharmaceuticals, Inc. (US)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 MedImmune (US)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 PROPHYLACTIC PEDIATRIC VACCINES MANUFACTURING COST ANALYSIS

7.1 Prophylactic Pediatric Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prophylactic Pediatric Vaccines

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Prophylactic Pediatric Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prophylactic Pediatric Vaccines Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES PROPHYLACTIC PEDIATRIC VACCINES MARKET FORECAST (2017-2021)

11.1 United States Prophylactic Pediatric Vaccines Production, Revenue Forecast (2017-2021)
11.2 United States Prophylactic Pediatric Vaccines Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Prophylactic Pediatric Vaccines Production Forecast by Type (2017-2021)
11.4 United States Prophylactic Pediatric Vaccines Consumption Forecast by Application (2017-2021)
11.5 Prophylactic Pediatric Vaccines Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prophylactic Pediatric Vaccines
Table Classification of Prophylactic Pediatric Vaccines
Figure United States Sales Market Share of Prophylactic Pediatric Vaccines by Type in 2015
Table Application of Prophylactic Pediatric Vaccines
Figure United States Sales Market Share of Prophylactic Pediatric Vaccines by Application in 2015
Figure United States Prophylactic Pediatric Vaccines Sales and Growth Rate (2011-2021)
Figure United States Prophylactic Pediatric Vaccines Revenue and Growth Rate (2011-2021)
Table United States Prophylactic Pediatric Vaccines Sales of Key Manufacturers (2015 and 2016)
Table United States Prophylactic Pediatric Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prophylactic Pediatric Vaccines Sales Share by Manufacturers
Figure 2016 Prophylactic Pediatric Vaccines Sales Share by Manufacturers
Table United States Prophylactic Pediatric Vaccines Revenue by Manufacturers (2015 and 2016)
Table United States Prophylactic Pediatric Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Prophylactic Pediatric Vaccines Revenue Share by Manufacturers
Table 2016 United States Prophylactic Pediatric Vaccines Revenue Share by Manufacturers
Table United States Market Prophylactic Pediatric Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Prophylactic Pediatric Vaccines Average Price of Key Manufacturers in 2015
Figure Prophylactic Pediatric Vaccines Market Share of Top 3 Manufacturers
Figure Prophylactic Pediatric Vaccines Market Share of Top 5 Manufacturers
Table United States Prophylactic Pediatric Vaccines Sales by Type (2012-2017)
Table United States Prophylactic Pediatric Vaccines Sales Share by Type (2012-2017)
Figure United States Prophylactic Pediatric Vaccines Sales Market Share by Type in 2015
Table United States Prophylactic Pediatric Vaccines Revenue and Market Share by Type (2012-2017)
Table United States Prophylactic Pediatric Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prophylactic Pediatric Vaccines by Type (2012-2017)
Table United States Prophylactic Pediatric Vaccines Price by Type (2012-2017)
Figure United States Prophylactic Pediatric Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Prophylactic Pediatric Vaccines Sales by Application (2012-2017)
Table United States Prophylactic Pediatric Vaccines Sales Market Share by Application (2012-2017)
Figure United States Prophylactic Pediatric Vaccines Sales Market Share by Application in 2015
Table United States Prophylactic Pediatric Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Prophylactic Pediatric Vaccines Sales Growth Rate by Application (2012-2017)
Table ALK - Abello A/S (Denmark) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table ALK - Abello A/S (Denmark) Prophylactic Pediatric Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table ALK - Abello A/S (Denmark) Prophylactic Pediatric Vaccines Market Share (2012-2017)
Table Altimmune, Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Altimmune, Inc. (US) Prophylactic Pediatric Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Altimmune, Inc. (US) Prophylactic Pediatric Vaccines Market Share (2012-2017)
Table Bavarian Nordic A/S (Denmark) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bavarian Nordic A/S (Denmark) Prophylactic Pediatric Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Bavarian Nordic A/S (Denmark) Prophylactic Pediatric Vaccines Market Share (2012-2017)
Table BiondVax Pharmaceuticals Ltd. (Israel) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Pediatric Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Pediatric Vaccines Market Share (2012-2017)
Table Bharat Biotech International Limited (India) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bharat Biotech International Limited (India) Prophylactic Pediatric Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Bharat Biotech International Limited (India) Prophylactic Pediatric Vaccines Market Share (2012-2017)
Table GlaxoSmithKline Plc. (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc. (UK) Prophylactic Pediatric Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc. (UK) Prophylactic Pediatric Vaccines Market Share (2012-2017)
Table Hualan Biological Engineering Inc. (China) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hualan Biological Engineering Inc. (China) Prophylactic Pediatric Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Hualan Biological Engineering Inc. (China) Prophylactic Pediatric Vaccines Market Share (2012-2017)
Table Janssen Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Janssen Pharmaceuticals, Inc. (US) Prophylactic Pediatric Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Pharmaceuticals, Inc. (US) Prophylactic Pediatric Vaccines Market Share (2012-2017)
Table MedImmune (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table MedImmune (US) Prophylactic Pediatric Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune (US) Prophylactic Pediatric Vaccines Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prophylactic Pediatric Vaccines
Figure Manufacturing Process Analysis of Prophylactic Pediatric Vaccines
Figure Prophylactic Pediatric Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Prophylactic Pediatric Vaccines Major Manufacturers in 2015
Table Major Buyers of Prophylactic Pediatric Vaccines
Table Distributors/Traders List
Figure United States Prophylactic Pediatric Vaccines Production and Growth Rate Forecast (2017-2021)
Figure United States Prophylactic Pediatric Vaccines Revenue and Growth Rate Forecast (2017-2021)
Table United States Prophylactic Pediatric Vaccines Production Forecast by Type (2017-2021)
Table United States Prophylactic Pediatric Vaccines Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

ALK - Abello A/S (Denmark)
Altimmune, Inc. (US)
Bavarian Nordic A/S (Denmark)
BiondVax Pharmaceuticals Ltd. (Israel)
Bharat Biotech International Limited (India)
GlaxoSmithKline Plc. (UK)
Hualan Biological Engineering Inc. (China)
Janssen Pharmaceuticals, Inc. (US)
MedImmune (US)
Merck & Co., Inc. (US)
Pfizer Inc. (US)
Sanofi Pasteur SA (France)
Serum Institute of India Pvt. Ltd. (India)
Shanghai BravoBio Co., Ltd. (China)
Seqirus (UK)
SK Chemicals Co., Ltd. (Korea)
Takeda Pharmaceutical Company Limited (Japan)
Zydus Cadila (India)